The Canadian Organization of Medical Physicists (COMP), in close partnership with the Canadian Partnership for Quality Radiotherapy (CPQR) has developed a series of Technical Quality Control (TQC) guidelines for radiation treatment equipment.
nes have been rigorously reviewed and field tested in a variety of Canadian radiation treatment facilities. The development process enables rapid review and update to keep the guidelines current with changes in technology (the most updated version of this guideline can be found on the CPQR website). This particular TQC details recommended quality control testing for medical linear accelerators and multileaf collimators. The development of the individual TQC guidelines is spearheaded by expert reviewers and involves broad stakeholder input from the medical physics and radiation oncology community. 1 Refer to the overarching document Technical Quality Control Guidelines for Canadian supporting this document; specific federal or provincial regulations and license conditions take precedence over the content of this document. Included in the scope of this document are multileaf collimators (MLCs); computer-controlled devices capable of providing photon beam shielding for linear accelerators using high density leaves (typically tungsten alloy) which are projected into the radiation field.
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In addition to static beam shaping, beam intensity modulation can also be achieved by adjusting the position of the MLC in the radiation field between treatment fields (step and shoot, or static inten- 
DL7
Gantry angle 0°, 100 cm source-axis distance (SAD). This test demonstrates the field edges are accurately defined by jaws and/or MLC leaves. It is sufficient to confirm a predefined field shape using the projected light field at isocenter. Tolerance and action levels apply to each edge of a rectangular field at isocenter as defined by the jaws/MLC leaves. Note that systems with a tertiary collimation MLC system will require both jaw and MLC leaf positions to be verified DL8 Output constancy must be verified for all photon energies in use on the particular treatment day. Measurement is to be conducted using standard local geometry using a dosimetry system calibrated against the local secondary standard system DL9 Output constancy must be verified for all electron energies in use on the particular treatment day. Measurement is to be conducted using standard local geometry using a dosimetry system calibrated against the local secondary standard system DL10 Wedge factors for a representative set of dynamic or virtual soft wedges in use on a particular treatment day must be verified. 
ML11
Measurements are made to confirm that the depth dose has not changed since commissioning the unit. Tolerance and action levels are specified in percentages for photon beams and in millimetres for electron beams. A single ratio of doses taken at clinically relevant depths is sufficient for these measurements. Alternatively, a tissue-phantom ratio (TPR) measurement or a check of profile constancy at a shallow depth could be used, and the tolerance and action levels adjusted appropriately
ML12
This test replaces testing of flatness and symmetry and is intended to be consistent with the testing suggested in American Association of Physicists in Medicine (AAPM) protocol TG-142. 14 The goal is to ensure that profiles are delivered in a manner consistent with that modeled in the associated treatment planning system. Tolerance and action levels refer to differences from commissioning (or baseline) profiles as defined in the AAPM protocol TG-142. 14 
L18
Specific to IMRT, this test demonstrates that the interplay of leaf velocity, gap width, gap position, and beam holds combine to deliver a planar dose map consistent with the prediction of the treatment planning system. A test plan should consider extreme conditions (e.g., the highest levels of modulation used clinically for each leaf pair). An acceptable alternative to this test is the regular (more than once per month) measurement of patient-specific, dynamic MLC IMRT fields. Tolerance and action levels are defined via the gamma metric comparing dose map differences (plan versus measurement). Dose maps are defined with region of interest threshold of 10% of the maximum dose. Dose differences are global (i.e., with respect to maximum dose). 14 Detector resolution must be sufficient to identify performance of individual leaves. As with all tests, tolerance and action levels may be tightened at the user's discretion
ML19
The synchronicity of all dynamic parameters during arc delivery is verified. Parameters may be evaluated independently, using a subset of the tests described by Ling et al. 15 or Bedford and Warrington, 16 or by the repeat delivery of a standard VMAT plan of suitable complexity, similar to test ML18. Tolerance and action levels are in reference to the consistency of dose delivered at different dose rate, gantry or MLC speeds. Tolerance levels should be based on the performance of the linear accelerator, whereas action levels should be set to achieve an overall precision consistent with other monthly tests (approximately 3%/2 mm from baseline) 
AL13
This test determines the diameter of the radiation isocenter defined by couch rotation through its full clinical range of motion. The diameter must be within specifications
AL14
The coincidence of radiation and mechanical isocenters is established for the collimator, gantry and couch. Coincidence must meet the specified limits
AL15
The three axes of rotation (the collimator/MLC, the couch, and the gantry) must meet within a sphere of the specified diameter.
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AL16
Couch deflection is measured as a difference in surface position (load versus no load) of the couch extended longitudinally at least 30 cm through isocenter. Under "load" is considered as a typical patient mass (approximately 70 kg) distributed over the couch or placed at the center. The difference is the couch deflection. Tolerance and action levels are defined relative to the deflection measured at the time of commissioning
AL17
The average and maximum MLC leaf transmission is verified in this test for all photon energies and compared with the values established at the time of commissioning or the values adopted in the treatment planning system. Tolerance and action levels refer to changes from the commissioning measurements
AL18
The average and maximum leakage between adjacent, closed MLC leaves is verified in this test for all photon energies and compared with the values established at the time of commissioning or the values adopted in the treatment planning system. Tolerance and action levels refer to changes from the commissioning measurements
AL19
The average and maximum leakage between abutting closed MLC leaves is verified in this test for all photon energies and compared with the values established at the time of commissioning or the values adopted in the treatment planning system. Tolerance and action levels refer to changes from the commissioning measurements AL20 Use a leaf pattern where one leaf from each leaf bank protrudes well into the field. Confirm the leaf edge parallelism with the collimator or solid jaw edge AL21 A dynamic leaf gap test (sometimes referred to as a dosimetric leaf gap test) is performed to confirm consistency with baseline measurements. The minimum standard is to establish this using a single detector (e.g., an ion chamber) method, although methods that calculate separate factors for each leaf pair may be employed. The value must be consistent within tolerance for all four cardinal gantry angles
AL22
To ensure redundancy and adequate monitoring, a second qualified medical physicist must independently verify the implementation, analysis, and interpretation of the quality control tests at least annually
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